With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
Anthony Palmieri, RPh, PharmD
Advertisement
Articles by Anthony Palmieri, RPh, PharmD
Advertisement
Latest Updated Articles
- Trends in Medication Utilization and the Cost of Treatment for Gout
Published: June 7th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
FDA Updates Boxed Warning for Cilta-Cel Following Reports of Immune Effector Cell–Associated Enterocolitis
5
